Literature DB >> 2547758

Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I.

W K Eng1, S D Pandit, R Sternglanz.   

Abstract

DNA topoisomerase I from the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe was overproduced using the cloned genes. Extracts from cells overproducing DNA topoisomerase I were prepared and incubated with 32P-labeled DNA. Alkali was used to trap the topoisomerase I-DNA covalent intermediate. Most of the DNA was digested with nuclease, and the resultant 32P-labeled topoisomerase I was subjected to cleavage with cyanogen bromide or formic acid. From the molecular weights of the resultant labeled peptides and by comparison of the amino acid sequences derived from the cloned genes, we were able to deduce that the active site tyrosine of eukaryotic DNA topoisomerase I is very near the carboxyl terminus, at amino acid 771 for S. pombe and 727 for S. cerevisiae. Site-directed mutagenesis was used to change tyrosine 727 of S. cerevisiae topoisomerase I to a phenylalanine. The resulting mutant topoisomerase I protein lost all DNA relaxation activity and rendered cells resistant to the topoisomerase I inhibitor, camptothecin. The amino acid sequence of human topoisomerase I has significant similarity to the two yeast topoisomerase I sequences. Based on this similarity, we infer that tyrosine 723 is the active site tyrosine of human enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.

Authors:  Aditi Das; Chhabinath Mandal; Arindam Dasgupta; Tanushri Sengupta; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

2.  Intramolecular synapsis of duplex DNA by vaccinia topoisomerase.

Authors:  S Shuman; D G Bear; J Sekiguchi
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

3.  The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.

Authors:  T Aso; D Haque; R J Barstead; R C Conaway; J W Conaway
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

4.  Translational maintenance of frame: mutants of Saccharomyces cerevisiae with altered -1 ribosomal frameshifting efficiencies.

Authors:  J D Dinman; R B Wickner
Journal:  Genetics       Date:  1994-01       Impact factor: 4.562

5.  Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; E M Kane; S G Morham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; I R Kirsch
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

7.  Isolation and characterization of a gene encoding DNA topoisomerase I in Drosophila melanogaster.

Authors:  T S Hsieh; S D Brown; P Huang; J Fostel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

8.  Human topoisomerase I mediates illegitimate recombination leading to DNA insertion into the ribosomal DNA locus in Saccharomyces cerevisiae.

Authors:  J Zhu; R H Schiestl
Journal:  Mol Genet Genomics       Date:  2004-03-06       Impact factor: 3.291

Review 9.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Cloning and characterization of the gene for the somatic form of DNA topoisomerase I from Xenopus laevis.

Authors:  S D Pandit; R E Richard; R Sternglanz; D F Bogenhagen
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.